Fundz

Sobi To Acquire Cti Biopharma Corp. Enhancing Sobi'S Position In Rare Haematology

May 10, 2023

Acquiring Company

Sobi

Acquired Company

CTI

StockholmCovingtonBiotechnologyHealth CareConsulting

Description

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) today announced that it has entered into an agreement and plan of merger with CTI BioPharma Corp. (CTI) under which Sobi has agreed to acquire CTI, a biopharmaceutical company focused on blood related cancers and rare diseases, by means of a tender offer.

Quick answer

Sobi is acquiring CTI, announced May 10, 2023. Sobi is based in Stockholm, Stockholm County, Sweden.

How much did Sobi pay for CTI?
The deal value was not disclosed.
What does Sobi do?
Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases.
Where are Sobi and CTI based?
Sobi is based in Stockholm, Stockholm County, Sweden. CTI is based in Covington, Kentucky, United States.
Who are the decision-makers at Sobi?
Fundz holds 1 contact at Sobi. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Consulting and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Sobi, and when

When Sobi changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Sobi raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sobi, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sobi. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sobi

Location

Stockholm, Stockholm County, Sweden

About

Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 1,600 employees across Europe, North America, the Middle East, Asia and Australia. In 2022, revenue amounted to SEK 18.8 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sobi makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Christer
Likely contact at this company
••••••••@••••••••

See Christer's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Sobi's next move

Learn about Strategic plan

Frequently asked

Who acquired CTI?

CTI was acquired by Sobi, based in Stockholm. The deal was reported on May 10, 2023. Sobi® is a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases. Sobi is privately held and operates in Biotechnology.

When did Sobi acquire CTI?

Sobi's acquisition of CTI was reported on May 10, 2023. Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) today announced that it has entered into an agreement and plan of merger with CTI BioPharma Corp. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does CTI do?

It is privately held, operating in Consulting, and is based in Covington.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.